9434
C. Fruit et al. / Tetrahedron 57 32001) 9429±9435
1
1000 cm21; H NMR /CDCl3) d 3.39 /s, 3H, OCH3), 4.81
/d, JCH,OH6.0 Hz, 1H, OH), 5.11 /s, 2H, OCH2), 6.06 /d,
JCH,OH6.0 Hz, 1H, CH), 6.98 /d, J9.0 Hz, 2H, HPh3,5),
7.30 /d, J9.0 Hz, 2H, HPh2,6), 8.24 /d, JH5,H62.0 Hz,
1H, H5), 8.46 /d, JH5,H62.0 Hz, 1H, H6); 13C NMR
/CDCl3) d 56.3 /OCH3), 71.9 /CH/OH)), 94.5 /OCH2),
116.6 /CPh3,5), 129.1 /CPh2,6), 134.2 /CPh1), 141.8 /C5),
143.2 /C6), 147.7 /C3), 155.4 /C2), 157.4 /CPh4); 15N NMR
/CDCl3) d 326 /d, J10.5 Hz, N1), 331 /d, J10.5 Hz, N4);
Anal. Calcd for C13H13ClN2O3: C, 55.62; H, 4.67; N, 9.98.
Found: C, 55.51; H, 4.82; N, 10.09.
1.1 mmol), para-anisaldehyde /0.13 mL, 1.1 mmol), t4 h
gave, after puri®cation by column chromatography on silica
gel /cyclohexane/ethyl acetate3:2), 8 /0.040 g, 25%) as a
yellow oil which crystallized: mp1078C /CH2Cl2); IR
/KBr) n 3423, 3002, 2934, 2836, 1609, 1511, 1305, 1251,
1
1174, 1156, 1032, 836 cm21; H NMR /CDCl3) d 3.76 /s,
3H, OCH3), 4.29 /d, JCH,OH6.9 Hz, 1H, OH), 5.98 /d,
JCH,OH6.9 Hz, 1H, CH), 6.85 /d, J8.7 Hz, 2H, HPh3,5),
7.24 /d, J8.7 Hz, 2H, HPh2,6), 8.54 /s, 1H, H5); 13C NMR
/CDCl3) d 55.1 /OCH3), 71.3 /CH), 114.0 /CPh3,5), 128.5
/CPh2,6), 131.9 /CPh1), 140.9 /C5), 145.2 /C6), 146.1 /C3),
153.0 /C2), 159.4 /CPh4); MS 284 /M1), HRMS 284.0119;
Anal. Calcd for C12H10Cl2N2O2: C, 50.55; H, 3.54; N, 9.82.
Found: C, 50.48; H, 3.66; N, 9.75.
3.4.4. 2-Chloro-3--1-hydroxy-4-methoxyphenylmethyl)-
6--1-hydroxyethyl)pyrazine -6). Metalation of 4 /0.300 g,
1.2 mmol) according to the general procedure /method A)
with n-butyllithium 1.6 M /2.3 mL, 3.7 mmol) and 2,2,6,6-
tetramethylpiperidine /0.65 mL, 3.8 mmol), t15 min, then
reaction with acetaldehyde /0.4 mL, 7.1 mmol), t45 min
gave, after puri®cation by column chromatography on silica
gel /cyclohexane/ethyl acetate1:1), 6 /0.200 g, 56%) as a
yellow oil: IR /KBr) n 3401, 2977, 2934, 2837, 1702, 1610,
1512, 1251, 1175, 1083, 1033, 756 cm21; 1H NMR /CDCl3)
d 1.49 /d, JCH,CH36.8 Hz, 3H, 1dia, CH3), 1.50 /d,
JCH,CH36.8 Hz, 3H, 1dia, CH3), 2.70 /p, 1H, OH), 3.70
/s, 3H, OCH3), 4.60 /p, 1H, OH), 4.89 /q, JCH,CH36.8 Hz,
1H, CH), 5.90 /s, 1H, CH), 6.77 /d, J8.7 Hz, 2H, HPh3,5),
7.18 /d, J8.7 Hz, 2H, HPh2,6), 8.56 /s, 1H, 1dia, H5), 8.57
/s, 1H, 1dia, H5); 13C NMR /CDCl3) d 24.11 /CH3, 1dia),
24.15 /CH3, 1dia), 55.7 /OCH3), 68.42 /CH/CH3), 1dia),
68.46 /CH/CH3), 1dia), 72.0 /CH/OH)), 114.4 /CPh3,5),
129.1 /CPh2,6), 132.94 /C6, 1dia), 132.98 /C6, 1dia), 138.6
/C5), 153.4 /C2), 158.53 /C3, 1dia), 158.57 /C3, 1dia), 159.9
/CPh4); Anal. Calcd for C14H15ClN2O3: C, 57.06; H, 5.19; N,
9.50. Found: C, 56.87; H, 5.55; N, 9.39.
3.4.7. 2-Chloro-3--1-hydroxy-4-methoxyphenylmethyl)-
6-iodopyrazine -9). Metalation of 4 /0.210 g, 0.8 mmol)
according to the general procedure /method A) with n-butyl-
lithium 2.5 M /1.0 mL, 2.5 mmol) and 2,2,6,6-tetramethyl-
piperidine /0.44 mL, 2.6 mmol), t15 min, then reaction
with iodine /0.240 g, 0.9 mmol), t120 min gave, after
puri®cation by column chromatography on silica gel /cyclo-
hexane/ethyl acetate3:2), 9 /0.200 g, 64%) as a red oil: IR
/KBr) n 3412, 3004, 2956, 2932, 2836, 1610, 1509, 1305,
1251, 1175, 1117, 1035, 832, 756 cm21; 1H NMR /CDCl3)
d 3.76 /s, 3H, OCH3), 4.28 /d, JCH,OH7.5 Hz, 1H, OH),
5.92 /d, JCH,OH7.5 Hz, 1H, CH), 6.87 /d, J8.7 Hz, 2H,
HPh3,5), 7.27 /d, J8.7 Hz, 2H, HPh2,6), 8.78 /s, 1H, H5); 13
C
NMR /CDCl3) d 55.3 /OCH3), 71.3 /CH), 111.5 /C6), 114.0
/CPh3,5), 128.6 /CPh2,6), 131.9 /CPh1), 146.4 /C3), 149.5 /C5),
153.6 /C2), 159.6 /CPh4); Anal. Calcd for C12H10ClIN2O2: C,
38.27; H, 2.68; N, 7.44. Found: C, 38.45; H, 2.76; N, 7.21.
3.4.8. 2-Chloro-3--1-hydroxy-4-methoxymethoxyphenyl-
methyl)-6-iodopyrazine -10). Metalation of 5 /2.873 g,
10 mmol) according to the general procedure /method A)
with n-butyllithium 2.5 M /12.4 mL, 31 mmol) and 2,2,6,6-
tetramethylpiperidine /5.2 mL, 31 mmol), t15 min, then
reaction with iodine /2.793 g, 11 mmol), t120 min gave,
after puri®cation by column chromatography on silica gel
/ether petroleum/ethyl acetate7:3), 10 /2.114 g, 52%) as
an orange oil which crystallized: mp668C /CH2Cl2); IR
/KBr) n 3478, 2954, 2897, 1607, 1509, 1415, 1388, 1306,
3.4.5. 2-Chloro-3--1-hydroxy-4-methoxyphenylmethyl)-
6--1-hydroxyphenylmethyl) pyrazine -7). Metalation of
4 /0.200 g, 0.8 mmol) according to the general procedure
/method A) with n-butyllithium 1.6 M /1.6 mL, 2.5 mmol)
and 2,2,6,6-tetramethylpiperidine /0.44 mL, 2.6 mmol),
t15 min, then reaction with benzaldehyde /0.1 mL,
1.0 mmol), t60 min gave, after puri®cation by column
chromatography on silica gel /cyclohexane/ethyl acetate
7:3), 7 /0.148 g, 52%) as a yellow oil: 1H NMR /CDCl3) d
3.36 /p, 1H, OH), 3.50 /p, 1H, OH), 3.75 /s, 3H, OCH3),
5.61 /s, 1H, CH), 5.92 /s, 1H, CH), 6.82 /d, J8.7 Hz, 2H,
HPh3,5), 7.30 /d, J8.7 Hz, 2H, HPh2,6), 8.60 /s, 1H, H5);
Anal. Calcd for C19H17ClN2O3: C, 63.96; H, 4.80; N, 7.85.
Found: C, 64.20; H, 4.67; N, 7.71.
1
1229, 1004, 834 cm21; H NMR /CDCl3) d 3.33 /s, 3H,
OCH3), 4.64 /p, 1H, OH), 5.04 /s, 2H, OCH2O), 5.87 /s,
1H, CH), 6.88 /d, J9.1 Hz, 2H, HPh3,5), 7.18 /d, J9.1 Hz,
2H, HPh2,6), 8.65 /s, 1H, H5);13C NMR /CDCl3) d 56.3
/OCH3), 71.7 /CH), 94.5 /OCH2O), 113.1 /C6), 116.6
/CPh3,5), 128.9 /CPh2,6), 133.7 /CPh1), 146.7 /C2), 150.1
/C5), 154.2 /C3), 157.5 /CPh4); 15N NMR /CDCl3) d 328.8
/s, N1), 330.1 /d, J10.5 Hz, N4); Anal. Calcd for
C13H12ClIN2O2: C, 38.40; H, 2.97; N, 6.89. Found: C,
38.67; H, 3.14; N, 7.28.
3.4.6.
methyl)pyrazine -8). 1st method: Metalation of
2,6-Dichloro-3--1-hydroxy-4-methoxyphenyl-
4
/0.330 g, 1.3 mmol) according to the general procedure
/method A) with n-butyllithium 1.6 M /2.5 mL, 4.0 mmol)
and 2,2,6,6-tetramethylpiperidine /0.71 mL, 4.2 mmol),
t15 min, then reaction with hexachloroethane /0.380 g,
1.6 mmol), t60 min gave, after puri®cation by column
chromatography on silica gel /cyclohexane/ethyl acetate
3:2), 8 /0.250 g, 61%) as a yellow oil which crystallized.
2nd method: Metalation of 2,6-dichloropyrazine 11
/0.150 g, 1.0 mmol) according to the general procedure
/method B) with n-butyllithium 2.5 M /0.44 mL,
1.1 mmol) and 2,2,6,6-tetramethylpiperidine /0.13 mL,
3.5. Synthesis of alkylpyrazines via cross-coupling
reaction with organozinc reagent
3.5.1. 6-n-Butyl-2-chloro-3--1-hydroxy-4-methoxyphenyl-
methyl)pyrazine -11) and 6-sec-butyl-2-chloro-3--1-
hydroxy-4-methoxyphenylmethyl)pyrazine -12). A solu-
tion containing 12.5 equiv. of zinc chloride /0.885 g,
6.5 mmol) /previously dried under vaccum with a ¯ameless
heat gun) dissolved in 5 mL of THF under an atmosphere of